메뉴 건너뛰기




Volumn 22, Issue 32, 2003, Pages 4953-4963

The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells

Author keywords

Apoptosis; Bax; Bcl 2; PS 341; TRAIL

Indexed keywords

ADAPTOR PROTEIN; BORTEZOMIB; CASPASE 2; CASPASE 8; CASPASE 9; CYTOCHROME C; FLICE INHIBITORY PROTEIN; PROTEASOME INHIBITOR; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL XL; PROTEIN DR5; RECEPTOR PROTEIN; TRAIL RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; BAX PROTEIN, HUMAN; BCL2L1 PROTEIN, HUMAN; BORONIC ACID DERIVATIVE; CASP9 PROTEIN, HUMAN; CASPASE; MEMBRANE PROTEIN; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN BCL X; PROTEINASE INHIBITOR; PYRAZINE DERIVATIVE; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

EID: 0043287140     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206656     Document Type: Article
Times cited : (171)

References (56)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.